Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period.
about
Incorporating children's toxicokinetics into a risk frameworkDevelopmental pharmacokinetics in pediatric populationsSystemic side effects of eye drops: a pharmacokinetic perspectiveXenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicityCytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohortThe incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patientsDifferences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary HepatocytesOntogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome.Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines.Human variability and susceptibility to trichloroethyleneTranscriptional ontogeny of the developing liver.Ethanol pharmacokinetics in neonates and infantsThe cytosolic chaperonin CCT/TRiC and cancer cell proliferation.Expression of CYP2W1 in colon tumors: regulation by gene methylation.Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.Differences between children and adults: implications for risk assessment at California EPA.Prophylaxis of postoperative nausea and vomiting in adolescent patients: a review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine.Developmental and pediatric pharmacogenomics.Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverReview and analysis of inhalation dosimetry methods for application to children's risk assessment.Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Summary of the National Institute of Child Health and Human Development-best pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group.Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.ATSDR evaluation of the health effects of zinc and relevance to public health.Modeling approaches for estimating the dosimetry of inhaled toxicants in children.Estimated blood alcohol concentrations for child and adolescent drinking and their implications for screening instruments.Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial.ATSDR evaluation of health effects of benzene and relevance to public health.Acrolein health effects.Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport.Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.The Promises of Quantitative Proteomics in Precision MedicineHuman placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes.Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.Neonatal pharmacology: extensive interindividual variability despite limited size.
P2860
Q24811056-EBA8E5B8-37AA-4B8E-9038-5DD7E04C9B7BQ27002933-CF8E6F2B-DDF9-472E-B27F-B13ACCC13067Q28066720-A516E6A9-8087-4CD7-A096-0F6C0FC2BBBFQ28264076-4F1BB654-C323-4E65-8C6A-99AFC69FC3B0Q28486869-8062DD69-2AB4-4174-ACD8-CC51E98B19BAQ28539060-CCE287A4-DFAB-4A5D-A4E6-F15842ABDD81Q28542785-51C69FA7-A4E5-4D6E-B9EC-B1A52BDB730FQ28546589-D4D58FE4-D163-495D-BAF5-EEC6B5BCC907Q31374965-F8183CC4-5D07-406A-A37E-362B297B60EBQ33729483-251567FC-80B4-4F3A-AFA3-0F70D7F96349Q33916686-F6C3B4F8-0EE8-4642-B530-7AB002675AACQ34133406-EF77D9B8-639F-48E6-BCBF-6B4E3EB9B26BQ34440525-B12DB3E8-56BF-45F3-A616-E40F886B465BQ34683808-3512F199-9E95-49A4-B63A-A64756C5ECF5Q34708842-54020A67-0BAB-41AF-90E3-7DF9AE90BD65Q34975651-7A7EB332-C2C7-4C50-A3F1-458B3389BD12Q34978971-9388AC3E-4C46-4331-ADA1-455E8FC82F6FQ35100946-5DD7771C-8695-42EE-A8E3-A64B7FAB6F02Q35116112-081AFB1F-4BC9-4669-A85B-FA945720D35AQ35827012-7FB277AF-C28D-4963-8407-710219409674Q35883284-B20EF636-5039-44CE-B21F-C8BEC04B2674Q36131290-F55027C3-6C75-41E7-803C-5BAA1E8A7D7AQ36213523-BE926024-2279-4E5E-9DBD-113063FB94F6Q36501845-6F05107C-833E-4CDE-A72D-9462D2FE1343Q36544972-D0E2B857-FD65-4650-B031-434A3384044AQ36833626-87039CD2-BC00-4B97-A540-0B6B213E5B35Q37039742-1C7F305A-2402-45D4-9EDB-0F87AD93025CQ37213069-A391F326-3CB7-4635-A906-40F1297194BAQ37322083-FE07930D-1BF3-4130-8BA3-02D164D53A2BQ37331135-48B912E5-05E2-4230-B8C6-13FB3D3B5834Q37333260-BE20A6E6-9E7A-4A1A-8224-0245C47B6363Q37576018-5FA251A5-3A5D-4E1D-8136-6D86DD0651FDQ37604379-452670E0-727C-402D-9C78-52600BFEC6B7Q37634334-BA7E8EBE-ECFC-4072-96A3-5048CEDC337BQ37647264-2D427C06-9EEE-4C04-A72C-273491484202Q37663399-F31F7786-EB61-4EDA-BFE2-0DF37E3A762CQ37698409-F3F7D029-440C-4DE7-B405-2371C484DB3EQ37823851-31449424-953A-44D0-8447-18D536366948Q37872784-7BD1466B-197B-4387-931F-AE130B7377B1Q38000252-917695DE-4003-4EAD-96BD-8C17AC82A359
P2860
Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Developmental expression of CY ...... on during the neonatal period.
@ast
Developmental expression of CY ...... on during the neonatal period.
@en
Developmental expression of CY ...... on during the neonatal period.
@nl
type
label
Developmental expression of CY ...... on during the neonatal period.
@ast
Developmental expression of CY ...... on during the neonatal period.
@en
Developmental expression of CY ...... on during the neonatal period.
@nl
prefLabel
Developmental expression of CY ...... on during the neonatal period.
@ast
Developmental expression of CY ...... on during the neonatal period.
@en
Developmental expression of CY ...... on during the neonatal period.
@nl
P2093
P2860
P1433
P1476
Developmental expression of CY ...... on during the neonatal period.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1996.0476Z.X
P407
P577
1996-06-01T00:00:00Z